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This book consists of the Proceedings of an Inter- 
national Symposium on Tocopherol, Oxygen and 
Biomembranes held in Japan in September 1977. 
The Proceedings have been published fairly rapidly, 
which is essential if they are to be of value as a view 
of current research. 
Perhaps the most useful feature of such a Sympo- 
sium is the time devoted to discussion. It is thus 
disappointing to find that this volume contains no 
account of the discussions that must have taken place, 
especially as the meeting contained a wide range of 
scientists, from pure chemists to clinicians. 
Nevertheless, to have papers ranging from purely 
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Books on cancer usually fall into one of two cate- 
gories, the specialist ‘heavy’ publications or the light 
journalistic pieces. Whereas the former are virtually 
incomprehensible to the general reader, the latter are 
written in that vague, optimistic, anticipatory style 
which conveys the impression that ‘breakthroughs’ 
by at least half of the scientists interviewed are immi- 
nent. Several years ago, Dr Braun, no doubt in an 
attempt to bridge this gap, wrote ‘The Biology of 
Cancer’ which for the first time laid down some 
ground rules for the emerging science of cancer. The 
new expanded edition, now entitled ‘The Story of 
Cancer’ continues in the same vein but with more 
detail and a broader coverage of the topic. The book 
chemical studies on the reactions of ar-tocopherol 
with singlet oxygen and superoxide to clinical trials 
of a-tocopherol in patients suffering from arterio- 
sclerosis collected together in the same volume is 
extremely useful. To workers in the free-radical field 
(such as myself), the papers by Lucy and others serve 
as a reminder that there is more to the action of 
tocopherol than its radical-scavenging ability. I would 
strongly recommend this book to all workers inter- 
ested in membrane stability and lipid peroxidation. 
B. Halliwell 
is published as a reasonably priced paperback of just 
over 300 pages of triple-spaced typescript and figures 
reduced to a convenient size. To my knowledge, the 
author has no competitors in this area, probably an 
indication of the difficulties involved in reviewing 
such a vast arena of factual information, often con- 
tradictory, always unorganised and, in the main, 
lacking underlying principles. 
The first 3 chapters comprise a neutral but infor- 
mative account of the history of cancer research, 
the biological concepts necessary to understand the 
current position, the distinguishing characteristics of 
tumour cells and their development in vivo. It is not 
until the 4th and 5th chapters that the bias of the 
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author is revealed. He is a vigorous partisan of the 
‘epigenetic’ camp which holds that most cancer does 
not involve a change in the structure of the genetic 
elements. The arguments put forward in support of 
this view in the chapter on epigenetic mechanisms 
and against the alternative in the chapter concerned 
with somatic mutation are well presented and very 
persuasive, until one recalls that all the examples 
chosen come from animal models or rare forms of 
human cancer and that most cases of this disease 
are caused by environmental factors, many of which, 
for example, cigarette tar carcinogens and radiation, 
react with DNA and cause mutation in test systems. 
After perusing the book from cover to cover, the 
reader may be a little perplexed about this issue for, 
in a later chapter, it is rightly stated that ‘70% or 
more of all human cancers are caused by environ- 
mental hazards’. The confusion results from regard- 
ing the environmentalist view as being synonymous 
with the mutationist view, a natural mistake. How- 
ever, the author obviously feels that a spontaneous 
internally-caused cancer or an externally-induced 
cancer could both be mediated via epigenetic mecha- 
nisms, and he may be correct. The book would benefit 
from an unambiguous statement to this effect, as it 
would from a less biased outlook overall. It would be 
impossible not to ‘take a view’ in a work of this nature, 
and of this size, and it must be admitted that strong 
evidence exists in certain, rather special systems, for 
example the teratocarcinoma, which indicates that 
neoplasia need not involve mutation. However, the 
evidence that most human tumours are monoclonal 
in origin as demonstrated by isoenzyme analysis, that 
virtually all agents shown to induce cancer are also 
mutagenic after activation, and that the major human 
cancers, for example those of the lung, breast, colon, 
stomach and prostate, are, to all intents and purposes, 
irreversible, could have been given more weight. How- 
ever, the author is to be congratulated on the clever 
way in which he has used this debate to present much 
of cancer phenomenology to the reader in a style 
which holds one’s interest. Without this argumentative 
theme, the data would be as dry as bran and equally 
indigestible, but that’s another story. 
On the general issue of priorities, the book is 
strangely balanced. Whilst only 16 pages are devoted 
to the environmental issue, 35 pages are reserved for 
discussion of plant tumours. Since these never metas- 
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tasize, it is questionable whether they are at all rele- 
vant as tumour models. Possibly some of this space 
could have been used to greater purpose for a discus- 
sion of not only the putative carcinogenic factors in 
our environment and their mechanism of action, but 
also the reasons why society cannot deal with the 
known carcinogens. For example, whilst over 40 000 
people undergo the torturous death from lung cancer 
annually in the U.K., cigarette sales are increasing 
particularly among women and children. We collec- 
tively spend Z3000 X lo6 p.a. on cigarettes of which 
the Government recoups %2000 X 106. Of this, it 
allots $1 X lo6 p.a. for the entire anti-smoking cam- 
paign, whilst allowing the tobacco companies to spend 
280 X lo6 on advertising. The Chairman of British 
American Tobacco Ltd. earned more in salary last 
year than the entire annual budget for ASH (Action 
on Smoking and Health, the group who provide 
statistics such as those mentioned above). Since it 
is likely that a total ban on tobacco advertising and 
the continual presentation on the media of hard- 
hitting factual adverts would result in a decline in 
the use of cigarettes, there is a relatively cheap way 
for the Government to reduce mortality. However, 
at the moment, little is being achieved in this direc- 
tion. Entrenched habits fortified by economic inter- 
ests constitute a formidable opposition to preventa- 
tive measures. To quote from a recent paper by the 
eminent cancer epidemiologist, Sir Richard Doll: 
‘I see no reason why the causes for the remaining 
common cancers should not be detected within 
one or two decades. That is not to say that it will 
be easy to prevent the disease. For if, as I suspect, 
these hazards are associated with the common 
diet of developing countries, the problems we are 
now having to face in preventing tobacco-induced 
cancer will seem childishly simple.’ 
Such matters as these are becoming crucially impor- 
tant in the current ‘story of cancer’. 
The section dealing with chemotherapy gives a 
basic introduction to the subject. However, two 
important aspects were not given the prominence 
they deserve. Accessibility of the tumour to the 
drug is highly relevant and probably explains why 
leukaemia can be treated so successfully. The immu- 
nogenicity of the cancer may also be a decisive factor. 
Burkitt’s lymphoma, a rare cancer found in African 
children, can be cured by relatively simple chemo- 
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therapy. Could this phenomenon be due to the fact 
that this tumour always bears Herpes virus antigens? 
A synergistic effect between antitumour antibodies 
and cytotoxic drugs has been demonstrated. These 
points alone may explain why it is that certain 
tumours are susceptible to chemotherapy whereas 
the majority are not. 
Contrary to the views expressed by the author, it 
is now generally recognised that tumour-s~ci~c 
antigens do not exist on most human tumours or on 
spontaneous animal tumours. They may bear increas- 
ed amounts of normal proteins or express foetal 
proteins but these are not recognised as foreign by 
the immune system. Unfortunately, tumour immu- 
nologists inva~ably work with chemic~ly- or viral-. 
ly-induced tumour systems which are strongly 
immunogenic. However, these have little resem- 
blance to the cancers een in our hospitals. It might 
be argued that since much human cancer is known 
to be induced by environmental chemicals, for 
example lung cancer, the amours should be immu- 
nogenic. However, it has been shown that if the chem- 
ical is administered over a long period in small doses, 
the drug raises only nonimmunogenic cancer, proba- 
bly due to the fact that at low levels such chemicals 
are not immunosuppressive. If then spontaneous or
lowdose che~c~y-induced tumours are not carry- 
ing antigens that can be recognised as foreign, immuno- 
therapy can only be applied to the virally-induced 
neoplasms. Although viruses may be involved as part 
of the multifactoral etiology of lymphomas, leukae- 
mias or cervical cancer, there is little evidence for 
their participation in the major human cancers. No 
data has appeared to alter the view of clinicians that 
they are dealing here with non-infectious diseases 
which explains why, after 20 years of intensive 
research, there is no sound immunotherapeutic 
treatment of cancer available. This aspect might 
have been emphasised more clearly. 
The rosy impression of steady progress pervading 
the concluding paragraphs is also a little misleading. 
As pointed out several years ago by Dan Greenberg, 
if the values for the % of patients with lung, breast, 
colorectal or stomach cancer who survive for five 
years are examined, it is found that these figures 
have not changed signi~can~y since 1950 despite 
the billions of dollars spent on cancer esearch. An 
uncharted breakthrough in fundamental knowledge 
or solution of the difficult social problems involved 
in prevention would seem to be necessary. The out- 
look therefore must be regarded as essentially gloomy. 
Despite these serious criticisms, the book can be 
recommended as a starting point for all those inter- 
ested in Cancer with a capital C, that is Cancer as a 
science in its own right. Besides timulating critical 
thought, and no author of a scientific work can ask 
for more, the text provides everal fascinating titbits. 
For example, there is a desc~ption of Fischer’s 
experiment in 1906 with the red dye Scharlach R 
which colours and transforms epithelial cells in vivo 
inducing a reversible proliferation and metastasis. 
Surely such a phenomenon warrants further research 
using modern techniques? And after this introduc- 
tion, any irnb~~ce in the reader’s conception of 
cancer could be redressed by consulting the following 
reviews : 
On tumour immunology, Hewitt, Brit. J. Cancer 
(1976) 33,241; Herberman, Biochim. Biophys. 
Acta (1977) 473,93; 
On mutation and cancer, Knudson, Cancer (1977) 
39,1882; 
On environmental spects, Cairns, Sci. Am, (1975) 
233,64; Doll, Nature (1977) 265, 589; 
On the Viral Etiology of Cancer - A Realistic 
Approach; Rapp and Reed, Cancer (1977) 40,419; 
On the lack of change in cancer survival rates, 
Enstram and Austin, Science (1977) 195,847; 
Particularly ‘A Naive Person’s Guide to the Cancer 
Cell’; Watts, World Med. (June 1977) pp. 17-25. 
This glimpse of the labyrinthine current literature 
should generate companion in the sympathetic reader 
for Dr Braun in his task as reviewer. We should all be 
grateful for an inexpensive, readable and informative, 
if somewhat controversial, text in this difficult area. 
C. J. Chesterton 
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